TSS
MREO

Two Sigma Securities’s Mereo BioPharma MREO Stock Holding History

Two Sigma Securities’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,926
Closed -$50.1K – 3356
2024
Q2 		$50.1K Buy
+13,926
New +$45.1K ﹤0.01% 2574
2022
Q4 		– Sell
-10,043
Closed -$9K – 3017
2022
Q3 		$9K Sell
10,043
-85,768
-90% -$105K ﹤0.01% 2416
2022
Q2 		$107K Buy
95,811
+81,811
+584% +$63.4K ﹤0.01% 1743
2022
Q1 		$16K Sell
14,000
-3,899
-22% -$5.04K ﹤0.01% 2003
2021
Q4 		$29K Buy
+17,899
New +$35.8K ﹤0.01% 1362

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Two Sigma Securities's MREO Position: Q3 2024 in Review

Two Sigma Securities sold out of Mereo BioPharma (MREO) in Q3 2024, closing a stake of 13,926 shares — an estimated $50.1K sold.

Two Sigma Securities first reported a position in MREO in Q4 2021 and held it in 5 quarters. The position peaked at $107K in Q2 2022. 77 funds tracked by Wall St. Rank hold MREO as of Q3 2024.

  • Two Sigma Securities reported no remaining Mereo BioPharma position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 13,926 Mereo BioPharma shares in Q3 2024, an estimated $50.1K.
  • Two Sigma Securities first reported a position in Mereo BioPharma in Q4 2021 and held it in 5 quarters.
  • Two Sigma Securities's Mereo BioPharma position peaked at $107K in Q2 2022.
  • 77 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.